GlaxoSmithKline PLC (NYSE:GSK)

During the Trading Day
48.47 +0.44 / +0.92%
Data as of 4:03pm ET
Day’s Change
During After-Hours   Switch to standard view »
48.53 +0.06 / +0.12%
 
Volume: 12.4K
Why AstraZeneca (AZN) Stock Is Up Today
8:01am / TheStreet.com
Zacks Rank #5 Additions for Thursday - Tale of the Tape
Jul 24 / Zacks.com
Novartis Division Gets European Approval for Simbrinza - Analyst Blog
Jul 28 / Zacks.com
What Will Puma Biotechnology Inc's $700 Million Man Do Next?
Jul 23 / MotleyFool.com
Markets Little Changed Ahead Of The Federal Reserve's Policy Decision
Jul 28 / Benzinga
Two Giants Blindsided by Major Trends
Jul 23 / TheStreet.com
What Makes Johnson & Johnson a Healthy Dividend Investment
Jul 28 / TheStreet.com
Why GlaxoSmithKline (GSK) Stock Continues To Sink Today
Jul 23 / TheStreet.com
Why GlaxoSmithKline (GSK) Stock Is Higher Today
Jul 28 / TheStreet.com
Puma Shares Soar When Wall Street Misplays Expectation Game
Jul 23 / TheStreet.com
GlaxoSmithKline, plc (GSK): New Analyst Report from Zacks Equity Research - Zacks Equ...
Jul 25 / Zacks.com
Why GlaxoSmithKline (GSK) Stock Is Falling Today
Jul 23 / TheStreet.com
Why GlaxoSmithKline (GSK) Stock Is Lower Today
Jul 25 / TheStreet.com
Heavy Volume And Pre-Market Movement For GlaxoSmithKline (GSK)
Jul 23 / TheStreet.com
GlaxoSmithKline (GSK) Weak In Early Morning Trading
Jul 25 / TheStreet.com
Here's What You Need to Know About AbbVie and GlaxoSmithKline's Upcoming Earnings
Jul 22 / MotleyFool.com
Today's Top Health Care Headlines: AbbVie and GlaxoSmithKline
Jul 25 / MotleyFool.com
Isis Pharma Initiates Phase II Study on ISIS-APO(a) - Analyst Blog
Jul 21 / Zacks.com
UCB's Brivaracetam Positive in Phase III Epilepsy Study - Analyst Blog
Jul 24 / Zacks.com
Novartis Misses on Q2 Earnings & Revenue, Outlook Retained - Analyst Blog
Jul 18 / Zacks.com
Were There Any Silver Linings in GlaxoSmithKline Stock's Earnings Failure?
Jul 24 / MotleyFool.com
Today's Top Health Care Stocks to Watch: AbbVie, GlaxoSmithKline, and Shire
Jul 17 / MotleyFool.com
Pharma, Biotech M&As Heat Up: Tax Inversion in Focus - Zacks Analyst Interviews
Jul 24 / Zacks.com
Theravance/Glaxo Commence Global Late stage Study on COPD - Analyst Blog
Jul 16 / Zacks.com
Pharma, Biotech M&As Heat Up: Tax Inversion in Focus - Industry Outlook
Jul 24 / Zacks.com
Roche Gets Priority Review for Avastin Label Expansion - Analyst Blog
Jul 16 / Zacks.com
3 Game-Changing Stories That Shook Investors: Inovio Pharmaceuticals, Gilead Sciences...
Jul 24 / MotleyFool.com
Should Roche Buy Exelixis?
Jul 16 / MotleyFool.com
Glaxo (GSK) Slips on Disappointing Q2 Earnings, Cuts View - Analyst Blog
Jul 24 / Zacks.com
China targets Apple for location-tracking apps
Jul 11 / CNNMoney.com

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.